Human Papillomavirus

mRNA Assay Less Sensitive Than DNA Assay for Latent HPV

mRNA Assay Less Sensitive Than DNA Assay for Latent HPV

Based on these data and the potential change in follow-up care, the HPV mRNA assay should not be used for a primary screening tool for cervical cancer.

Findings Support Nonavalent HPV Vaccine Use in Women With HIV

Findings Support Nonavalent HPV Vaccine Use in Women With HIV

By

The HR-HPV types covered by the nonavalent HPV vaccine had similar clearance rates to HR-HPV types not included, and women infected with multiple anogenital HR-HPV types had lower rates of clearance than women infected with only 1 type.

HPV Vaccination: Should Adolescents Be Allowed to Give Consent?

HPV Vaccination: Should Adolescents Be Allowed to Give Consent?

By

Adolescent consent may help minimize delays in vaccination and reduce the overall incidence of cervical, oropharyngeal, and anal cancers.

Improving HPV Vaccination Rates via Bundled Intervention

Improving HPV Vaccination Rates via Bundled Intervention

A bundled intervention including communication skills training and performance feedback may improve human papillomavirus vaccination.

HPV Vaccine Completion Rates in Adolescents Improve With Physician Communication

HPV Vaccine Completion Rates in Adolescents Improve With Physician Communication

For adolescents, a health care professional HPV vaccine communication intervention is associated with improved HPV vaccine series initiation and completion.

Prevalence of HPV16 High Among HIV-Positive Men Having Sex With Men

Prevalence of HPV16 High Among HIV-Positive Men Having Sex With Men

By

Study confirms HPV16 as an important determinant of high-grade lesions and supports its place as a priority for anal cancer prevention.

Reducing Treatment of HPV+ Oropharyngeal Cancer May Compromise Safety

Reducing Treatment of HPV+ Oropharyngeal Cancer May Compromise Safety

Deintensification of treatment from chemoradiotherapy to one modality may compromise safety in patients with human papillomavirus (HPV)+ stage 1 or 2 oropharyngeal cancer.

Limitations With Herd Immunity From Vaccine-Type Human Papillomavirus

Limitations With Herd Immunity From Vaccine-Type Human Papillomavirus

By

The limitations of herd protection for vaccine-type HPV was examined in a recent study.

Seminal HPV Infection Prevalent Worldwide, May Affect Male Fertility

Seminal HPV Infection Prevalent Worldwide, May Affect Male Fertility

By

Study was the first to examine the geographical variation of seminal HPV prevalence, showing a relatively high prevalence in fertility clinic attendees when compared to the general population.

HPV-Linked Cancer Survival Rates Differ Based on Social Disparities

HPV-Linked Cancer Survival Rates Differ Based on Social Disparities

For patients with HPV-associated cancers, there are large disparities in survival based on sex, race, and age.

HPV and Cytology Co-Testing Lowers Risk of Cervical Cancer

HPV and Cytology Co-Testing Lowers Risk of Cervical Cancer

Successive negative HPV and cytology co-testing is linked decrease risks of cervical cancer.

Efficacy of 9-Valent HPV Vaccine in Young Women

Efficacy of 9-Valent HPV Vaccine in Young Women

By

Findings inform further refinement of cervical cancer screening algorithms for vaccinated populations.

HPV Vaccine Linked to Lower Respiratory Papillomatosis Rates

HPV Vaccine Linked to Lower Respiratory Papillomatosis Rates

Incidence of juvenile-onset respiratory papillomatosis declined with the introduction of a HPV vaccination program.

Primary HPV Testing Recommendation Among US Physicians

Primary HPV Testing Recommendation Among US Physicians

By

Many US physicians recommended primary HPV testing for women of all ages, contrary to guidelines which limit this screening approach to women ≥25 years old.

Oral HPV Prevalence Higher in Men With Concurrent Genital HPV

Oral HPV Prevalence Higher in Men With Concurrent Genital HPV

By

The incidence of HPV-related oropharyngeal squamous cell carcinoma has increased in men dramatically and that increase is projected to continue until 2060.

Managing Comorbidities and Coinfections in HIV: Interview With Rajesh T. Gandhi, MD

Managing Comorbidities and Coinfections in HIV: Interview With Rajesh T. Gandhi, MD

Rajesh T. Gandhi, MD, discusses management of coinfections, including HPV and sexually transmitted infections, in people with HIV.

Vaccine-Type HPV Rates Low in Unvaccinated Women

Vaccine-Type HPV Rates Low in Unvaccinated Women

From 2009-2010 to 2013-2014, there was a decrease in the prevalence of vaccine-type human papillomavirus among unvaccinated young women, which suggests they are beginning to benefit from herd immunity.

HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes

HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes

By

Inadvertent administration of the quadrivalent HPV vaccine during periconception or pregnancy was not associated with additional risk to mothers and their infants.

HPV Vaccination Rates Lower Among Cancer Survivors

HPV Vaccination Rates Lower Among Cancer Survivors

By

Human papillomavirus vaccine initiation rates are low among young cancer survivors.

Surgery Improves HPV Related Oropharyngeal SCC Survival Rate

Surgery Improves HPV Related Oropharyngeal SCC Survival Rate

Patients with HPV-associated oropharyngeal squamous cell carcinoma have higher 5-year overall survival rates after surgery.

Women With HIV Have Higher Cervical Cancer Progression

Women With HIV Have Higher Cervical Cancer Progression

By

Women with HIV are more likely to experience progressive cervical changes.

Survivors of Anal Cancer Have Higher Risk of HPV-Related Second Cancers

Survivors of Anal Cancer Have Higher Risk of HPV-Related Second Cancers

Survivors of anal cancer have an elevated risk of HPV-related second primary malignancies.

Predictors of Parental Intent to Vaccinate Against HPV

Predictors of Parental Intent to Vaccinate Against HPV

Maternal education, Hispanic ethnicity, and provider recommendations are associated with parental intent to vaccinate adolescents against HPV.

New HPV Vaccination Recommendations Effective Against Genital Warts

New HPV Vaccination Recommendations Effective Against Genital Warts

Two rather than 3 doses of the human papillomavirus vaccine is enough to protect against genital warts in preteens and teens.

Oral HPV Risk Substantially Reduced With HPV Vaccine

Oral HPV Risk Substantially Reduced With HPV Vaccine

The human papillomavirus (HPV) vaccine offers a higher degree of protection in oral HPV infections.

Adolescent HPV Vaccination Rates Improve With Parental Self-Persuasion

Adolescent HPV Vaccination Rates Improve With Parental Self-Persuasion

By

Self-persuasion method facilitates HPV vaccination better than external persuasion in low literacy, safety-net settings.

CDC: Nearly Half of US Adults Infected With HPV

CDC: Nearly Half of US Adults Infected With HPV

HPV vaccine has the potential to reverse the epidemic and prevent thousands of cancers in the United States each year.

New Guideline on HPV Vaccine for Cervical Cancer Prevention

New Guideline on HPV Vaccine for Cervical Cancer Prevention

By

The American Society of Clinical Oncology issued new recommendations based on 4 levels of resource settings on human papillomavirus vaccination for cervical cancer prevention.

Educating High School Students Increases HPV Vaccination Rates

Educating High School Students Increases HPV Vaccination Rates

By

After a 30-minute educational session with high school seniors, basic knowledge of human papillomavirus and the benefits of HPV vaccination significantly increased.

Predictors of Distant Metastases in HPV-Positive Oropharyngeal Cancer

Predictors of Distant Metastases in HPV-Positive Oropharyngeal Cancer

Distant metastases rates are up in patients with HPV-positive oropharyngeal cancer, who actively smoke or have T4 tumors.

Sign Up for Free e-newsletters